Faendrich
Latest round
- Series A
Last raised
- May 2023
Total raised
- $4.3M
Investors
- 1
About Faendrich
Established in 2020 and based in Shanghai, China, Faendrich is a biotech company that focuses on immune cell research services. As of 2023, this company's proprietary OPM immune cell cells have completed three international clinical studies on organ transplantation: TAIC-I, TAIC-II and The One Study Mreg trial. The company is engaged in immune cell research, clinical application research, and cell technology services.
Who invested in Faendrich
1 investor across 1 round
See all investors in Faendrich
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 4, 2023
Amount
$4.3M
Investors
Questions about Faendrich
Who invested in Faendrich?
Faendrich has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Faendrich raised?
Faendrich has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Faendrich last raise money?
Faendrich's most recent round on record is a Series A, in May 2023.
What does Faendrich do?
Established in 2020 and based in Shanghai, China, Faendrich is a biotech company that focuses on immune cell research services.
Where is Faendrich headquartered?
Faendrich is headquartered in Shanghai, China.
Which VCs invest in companies like Faendrich?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Faendrich's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Faendrich? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.